Markers of oxidative stress, skeletal muscle mass and function, and their responses to resistance exercise training in older adults by Carru, Ciriaco et al.
 1 
 
Markers of oxidative stress, skeletal muscle mass and function, and their responses to 
resistance exercise training in older adults 
 
Ciriaco Carrua,b, Mariasole Da Boitc, Panagiotis Paliogiannisa, Angelo Zinellua, Salvatore 
Sotgiaa, Rachael Sibsond, Judith R. Meakine, Richard M. Aspdend, Arduino A. Mangonif, 
Stuart R. Grayg 
 
a Department of Biomedical Sciences, University of Sassari, Sassari, Italy; b Quality Control 
Unit, University Hospital (AOUSS), Sassari, Italy; c Faculty of Health and Life Sciences, De 
Montfort University, Leicester, United Kingdom; d Institute of Medical Sciences, University 
of Aberdeen, Aberdeen, United Kingdom; e Exeter MR Research Centre, University of 
Exeter, Exeter, United Kingdom; f Department of Clinical Pharmacology, College of 
Medicine and Public Health, Flinders University, Adelaide, Australia; g Institute of 
Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.  
 
Funding: this work was supported by the Biotechnology and Biological Sciences Research 
Council, United Kingdom (grant number BB/J015911/1). 
 
Corresponding author: Prof Ciriaco Carru, Department of Biomedical Sciences, University of 
07100 Sassari, Sassari, Italy. Tel: +39079229775; Email: carru@uniss.it 
 
Word count: 2,914 
 
Abstract 
 2 
Background: Oxidative stress (OS) negatively affects skeletal muscle homeostasis in 
experimental models of ageing. However, little is known about the associations between 
circulating OS markers and parameters of muscle mass and function, and their responses to 
exercise training, in humans.  
Methods: Maximal voluntary contraction (MVC, primary outcome) and isokinetic torque of 
the knee extensors at 30° s-1 (MIT), muscle cross-sectional area (MCSA) and quality (MQ, 
secondary outcomes), and plasma concentrations of malondialdehyde (MDA, pro-OS), 
homocysteine (HCY, pro-OS), taurine (TAU, anti-OS), and protein sulfhydryl groups (PSH, 
anti-OS) were measured in 27 healthy older males and 23 females at baseline and after an 18-
week resistance exercise program, with or without a nutritional intervention (fish oil vs. 
placebo).  
Results: After adjusting for age, glomerular filtration rate, and nutritional intervention, there 
were no significant correlations between baseline OS markers and muscle parameters, barring 
a positive association between TAU and MIT in females (r=0.53, P=0.035) and between 
MDA and MCSA in males (r=0.69, P=0.001). Training did not significantly change OS 
markers, except for a reduction in MDA in females (-0.27 µmol/L, 95% CI -0.51 to -0.02, 
P=0.034). In females, there were significant correlations between baseline MDA and 
exercise-induced changes in MVC (P=0.018), baseline TAU and changes in MCSA 
(P=0.026), and baseline HCY and changes in MCSA (P=0.046) and MQ (P=0.022). In males, 
baseline MDA was significantly associated with exercise-induced changes in MVC 
(P=0.040). 
Conclusions: Plasma MDA, HCY, and TAU were significantly associated with baseline 
and/or exercise-induced changes in muscle mass and function in healthy older adults, 
primarily in females. Pending further confirmation in other populations, specific OS markers, 
particularly MDA, might predict muscle responses to resistance exercise programs in old age.  
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1. Introduction 
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Ageing is associated with intracellular and extracellular morphological and functional 
changes, resulting in the progressive impairment of organ function and the development of 
disease states. One typical example is the significant decline in neuromuscular function and 
performance associated with the reduction of skeletal muscle mass (sarcopenia), which results 
in impaired muscle strength and physical performance (Hunter et al., 2016, Cruz-Jentoft et al., 
2010, Morley et al., 2011). The estimated prevalence of sarcopenia in old age ranges between 
25-50% (Patel et al., 2013). The progressive increase in the number of frail older adults will 
inevitably lead to an increased prevalence of sarcopenia, and its associated health-care costs, 
worldwide (Muscaritoli et al., 2010, Visser and Schaap, 2011). 
Many factors have been proposed to play a role in the pathogenesis of sarcopenia, including 
physical inactivity, alterations in protein metabolism and hormones, neurodegeneration, 
inflammation, and oxidative stress (OS) (Rolland et al., 2008). There is good evidence that 
the process of ageing is associated with increased concentrations of reactive oxygen and/or 
nitrogen species (RONS), and a reduction in endogenous antioxidants, in the skeletal muscle 
(Reid and Durham, 2002). This can lead to modifications of nucleic acids, proteins and lipids, 
resulting in molecular damage and/or dysfunction.  
High concentrations of RONS have been shown to negatively affect muscle mass and 
function by altering the balance between protein synthesis and proteolysis (Fulle et al., 2004, 
Powers et al., 2011). However, the assessment of the effect of OS on skeletal muscle 
homeostasis has primarily been conducted in in-vitro studies and animal models, and the 
generalizability of these findings in humans is uncertain (Ji, 2015, Scicchitano et al., 2017). 
The investigation of circulating markers of OS in older adults might be particularly useful for 
the identification of those at risk of developing sarcopenia and/or responders to specific 
interventions, such as exercise training.  
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The aim of this study was to investigate the associations between predefined pro-OS and anti-
OS markers and established parameters of skeletal muscle mass and function, and their 
responses to an exercise training and nutritional intervention program, in healthy older adults. 
Since the direct measurement of OS markers in tissue or body fluids is challenging, we 
measured plasma concentrations of oxidation target products such as malondialdehyde 
(MDA), low molecular thiol (HCY), and the antioxidants sulfhydryl group of proteins (PSH) 
and taurine (TAU). 
 
2. Methods 2.1. Study population 
We recruited 50 community-dwelling adults >65 years old (27 males and 23 females) that 
were not participating in any resistance exercise training, had no history of cardiovascular 
disease, cancer, arthritis, respiratory disease, metabolic disease, recent fractures and loss of 
mobility, and did not take regular analgesics or nutritional supplements. However, one female 
was prescribed angiotensin converting enzyme inhibitors for mild hypertension, and one male 
was prescribed allopurinol for gout. The study was approved by the University of Aberdeen 
College of Life Sciences and Medicine Ethics Review Board (CERB/2011/6/644) and 
registered at clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT02843009). Written consent 
was obtained after explaining the aims, risks, and potential discomfort, in accordance with the 
declaration of Helsinki. Participants were part of a study investigating the effects of fish oil 
consumption on adaptations to resistance exercise, and were randomly assigned to either 3.0 
g/day safflower oil or 3.0 g/day fish oil with data on other aspects of the project published 
elsewhere (Da Boit et al., 2017).  
2.2. Resistance exercise training 
 6 
Resistance exercise training was performed twice weekly for 18 weeks. Each session included 
four sets of nine repetitions for each exercise: leg press, leg extension, leg curl and calf press. 
The load for each exercise was set at 70% of the participant’s one repetition maximum 
(1RM). This was assessed for each exercise at baseline and every six weeks, and the load 
adjusted accordingly. 
2.3. Parameters of muscle mass and function 
The following measurements were performed the morning after an overnight fast, as 
previously described (Da Boit et al., 2017). Measurements were made prior to and at least 48-
h after the completion of the resistance exercise training intervention. 
2.3.1. Knee extensor isometric and isokinetic torque 
The maximal isometric torque of the knee extensor muscles of the right leg was determined 
during a maximal voluntary contraction (MVC) with the participant seated on a Biodex 
dynamometer with a knee angle of 73°. With the same seating position, maximal isokinetic 
torque (MIT) of the knee extensors was measured at 30° s-1. 
2.3.2. Magnetic resonance imaging (MRI) 
Forty-five participants underwent MRI (3 others were claustrophobic and 2 had metal 
implants) on a Philips Achieva 3.0 Tesla whole body scanner using a 16-channel SENSE XL 
Torso coil. Muscle cross-section area (MCSA) was quantified mid-thigh. Muscle quality 
(MQ) was calculated as torque (knee extensor isometric strength) per unit MCSA. 
2.4. Anthropometric and OS parameters 
Body weight and height were measured, and body mass index (BMI) calculated, for each 
study participant at baseline. Blood samples were collected by venipuncture in K+ EDTA 
vacutainers, placed on ice and processed within 30 min. After samples were centrifuged for 
10 min at 4 °C at 800g plasma was aliquoted and stored at -80°C until analysis. MDA was 
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determined by spectrophotometry according to an established method (Esterbauer and 
Cheeseman, 1990). Briefly, plasma was mixed with 0.075% thiobarbituric acid and incubated 
at 95 °C for 30 min. MDA concentration was assayed by measuring the absorbance at 535 nm 
using a MDA standard curve. Protein–SH (PSH) was assessed by spectrophotometry at 405 
nm using 5,5’, dithiobis-2-nitrobenzoic acid (Ellman, 1959). PSH concentration was 
determined using a glutathione standard curve and then normalized versus protein plasma 
quantity measured by the Lowry’s method. The low molecular weight thiols HCY, and TAU 
were determined by capillary electrophoresis (CE) with Laser Induced Fluorescence detection 
(Carru et al., 2004, Zinellu et al., 2003, Zinellu et al., 2009). Following protein precipitation 
with trichloroacetic acid, samples were derivatized using 5-(Iodoacetamido)fluorescein as 
fluorophore for HCY, and with fluorescein isothiocyanate for TAU. Following dilution, 
samples were injected in CE. Plasma creatinine and creatine concentrations were measured 
using an Aquity UPLC coupled to a qToF Premier high-resolution mass spectrometer 
(Waters, Sydney, Australia). Estimated glomerular filtration rate (eGFR) was measured using 
the Modification of Diet in Renal Disease formula (Levey et al., 1999). 
2.5. Statistical analysis  
Results are expressed as means ± SD, medians and interquartile ranges, or frequencies as 
appropriate. After testing for normal distribution, using the Kolmogorov-Smirnov test, 
between-group differences were assessed either by one-way ANOVA or Mann-Whitney U 
test. Differences between baseline and post-exercise muscle mass and function were assessed 
either by paired Student’s t-test or Wilcoxon test. In each sex, the effects of exercise and 
nutritional intervention on OS markers were assessed by ANCOVA. Partial correlations, 
adjusted for age, eGFR, and nutritional intervention, assessed the relationship between 
baseline OS markers and parameters of skeletal muscle mass and function, and their changes 
after the exercise training (MVC: primary outcome; MIT, MCSA and MQ: secondary 
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outcomes). Analyses were performed using IBM SPSS Statistics Version 23, Release 23.0.0.2 
(SPSS Inc., Armonk, NY, USA). A two-sided P<0.05 indicated statistical significance. 
 
3. Results 3.1. Baseline characteristics 
MVC, MIT, MCSA, and plasma creatinine, HCY and PSH concentrations were significantly 
higher in males. By contrast, plasma creatine concentrations were significantly higher in 
females (Table 1). MQ and TAU and MDA concentrations were similar in both sexes.  
3.2. Effect of exercise on muscle parameters and OS markers 
The resistance exercise training program significantly increased MVC (31±24%, P<0.001), 
MIT (12±18%, P<0.001), MCSA (3±5%, P<0.001) and MQ (27±26%, P<0.001) in the whole 
group. There were no significant exercise-induced changes in OS markers, except for a 
significant reduction in MDA concentrations in females (Table 2).  
3.3. Females 
3.3.1. Baseline 
There were no significant correlations between OS markers and parameters of muscle mass 
and function, barring a significant positive correlation between TAU and MIT (Table 3). 
3.3.2. Exercise-induced changes 
There was a significant positive correlation between baseline HCY and changes in MCSA, 
and a negative correlation between baseline HCY and changes in MQ (Table 4). Significant 
positive correlations were also observed between baseline TAU and changes in MCSA, and 
between baseline MDA and changes in MVC (Table 4).     
3.4. Males  
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3.4.1. Baseline 
There were no significant correlations between baseline OS markers and muscle parameters, 
barring a significant positive association between MDA and MCSA (Table 5). 
3.4.2. Exercise-induced changes  
There were no significant correlations between baseline OS markers and changes in muscle 
parameters, barring a significant positive association between MDA and changes in MVC 
(Table 6). 
 
4. Discussion 
Many efforts have been recently made to identify effective strategies to prevent and treat 
sarcopenia, including targeted pharmacological treatments, hormone replacement therapies, 
antioxidant-nutritional interventions, and physical exercise (Cruz-Jentoft et al., 2010, Morley 
et al., 2011). Among them, physical exercise has been shown to be particularly effective by 
increasing muscle strength, mass, and physical performance (Yoshimura et al., 2017). The 
identification of circulating biomarkers associated with parameters of muscle mass and 
function would be useful not only for sarcopenia risk stratification but also to predict the 
response to exercise training programs in older adults.  
In this study, we investigated associations between predefined markers with either pro-OS or 
anti-OS activity and parameters of muscle structure and function, at baseline and after a 
resistance exercise training and nutritional intervention program, in a group of healthy older 
adults. At baseline, there were no significant correlations between OS markers and muscle 
parameters, except for a positive association between TAU and MIT in females and between 
MDA and MCSA in males. There were no significant exercise-induced changes in the 
concentrations of OS markers in either sex, except for a significant reduction in MDA in 
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females. In females, there were significant correlations between baseline MDA and exercise-
induced changes in MVC, TAU and changes in MCSA, and between baseline HCY and 
changes in MCSA and MQ. In males, baseline MDA was significantly associated with 
exercise-induced changes in MVC. Therefore, the pro-OS MDA and HCY and the anti-OS 
TAU, but not PSH, showed significant associations with baseline and/or exercise-induced 
changes in skeletal muscle mass and function. In particular, baseline MDA concentrations 
predicted exercise-induced changes in MVC, the primary outcome, in both sexes.  
MDA, the enzymatic and non-enzymatic product of prostaglandins breakdown, endoperoxide, 
and the end product of lipid peroxidation (Ayala et al., 2014), is useful for the monitoring of 
serum free radicals. The latter are difficult to measure directly because of their relatively low 
stability. Animal and human studies have investigated the effects of chronic (weeks to 
months) exercise on MDA concentrations. However, in these studies it was not possible to 
investigate the associations between plasma/serum MDA and skeletal muscle parameters 
because a) MDA concentrations were measured in specific tissues, and b) parameters of 
muscle mass and function were not assessed. Ravi Kiran et al. studied the effects of different 
intensities and durations of swim training sessions, six days/week for four weeks, on 
myocardial MDA concentrations in young and old rats. A significant exercise-induced 
reduction in myocardial MDA concentrations was observed in both groups (Ravi Kiran et al., 
2006). Pangkahila et al. studied the effects of eight-week conventional training or balanced 
physical exercise on serum MDA, but not muscle parameters, in 24 males aged 18-30 years. 
MDA concentrations, measured before and after a training session at baseline and eight weeks 
later, were not significantly different over time and between the groups (Pangkahila et al., 
2016). In our study, the exercise-associated reduction in plasma MDA concentrations was 
statistically significant in females but not in males. This suggests that resistance exercise 
training might have beneficial effects on lipid peroxidation in older individuals, particularly 
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women. However, the observed reduction in MDA concentrations might also be an indirect 
result of the improvement in the control of free radical production by the mitochondria 
(Daussin et al., 2012). Notably, the observed associations between baseline MDA 
concentrations and changes in MVC in both sexes support the potential role of MDA in the 
identification of those individuals that are more likely to respond, in terms of muscle strength, 
to resistance exercise training. 
By contrast, the exercise program exerted opposite, albeit not significant, effects on plasma 
TAU concentrations in males (decreased) and females (increased). Baseline TAU 
concentrations were significantly correlated with baseline MIT and with exercise-induced 
changes in MSCA in females, but not in males. TAU plays an important role in several 
physiological functions, including cell signaling and development, membrane stability and 
receptor regulation, and various antioxidant and metabolic effects (Huxtable, 1992). 
Furthermore, it regulates the release of Ca2+ from the sarcoplasmic reticulum and maintains 
the sensitivity of contractile elements to Ca2+, affecting directly the excitation-contraction 
process and skeletal muscle strength (Spriet and Whitfield, 2015). Animal and human studies 
have previously investigated the effects of TAU supplementation on skeletal muscle mass and 
function and the effects of acute exercise on TAU concentrations, however no study has 
sought to determine the effects of chronic exercise on TAU concentrations in humans. In our 
study, 18-weeks of resistance exercise training significantly increased all parameters of 
skeletal mass and function in males, despite the trend towards a reduction in plasma TAU 
concentrations. This suggests that TAU concentrations are unlikely to play a significant role 
in the observed exercise-induced changes in muscle parameters in this group. By contrast, the 
significant correlations between baseline TAU and exercise-induced changes in MSCA in 
females suggest, similarly to MDA, a potential role of this sulfur-containing β-amino acid in 
the identification of female responders to exercise training programs. 
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Resistance exercise training did not significantly change plasma HCY concentrations in both 
sexes. However, baseline plasma HCY concentrations were positively associated with 
exercise-induced changes in MCSA, and negatively associated with changes in MQ, in 
females but not in males. Human studies have previously investigated the associations 
between HCY concentrations, physical exercise, and muscle strength. Steenge et al reported a 
non-significant reduction in plasma HCY concentrations (-0.6 µmol/L, 95% CI -1.9 to 0.5) in 
healthy women aged 19-38 years undergoing an eight-week period of resistance exercise, 
with three sessions each week involving leg squats, leg presses, leg curls, leg rowing, leg 
extensions, shoulder presses, sit-ups, and step-up exercises (Steenge et al., 2001). In a cross-
sectional study, Kuo et al observed a significant negative association between plasma HCY 
concentrations and peak quadriceps strength in 1,677 older adults from the National Health 
and Nutrition Examination Survey 1999-2002 (Kuo et al., 2007). In another cross-sectional 
study of 2,919 older adults with hyperhomocysteinemia, Swart et al reported that plasma 
HCY concentrations were not independently associated with skeletal muscle mass, however 
they were independently associated with reduced handgrip strength in women (P=0.02) but 
not in men (Swart et al., 2013a). By contrast, in a study of 1,301 older adults from the 
Longitudinal Aging Study in Amsterdam, Swart et al observed an independent negative 
association between plasma HCY concentrations and reduced handgrip strength in men 
(P<0.01) but not in women. However, HCY concentrations did not predict the changes in 
handgrip strength after a three-year follow up (Swart et al., 2013b). We did not observe any 
significant correlation between plasma HCY concentrations and baseline and exercise-
induced changes in parameters of muscle strength, MVC and MIT, in both sexes. However, 
similarly to TAU, the correlations with changes in MCSA and MQ in females warrant further 
research to clarify the potential predictive role of this highly reactive and pro-oxidant amino 
acid in subjects undergoing exercise training programs.     
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Although baseline PSH concentrations were significantly higher in males than in females, we 
did not observe any significant exercise-induced changes in PSH concentrations, or 
associations between PSH and parameters of muscle mass and function. In accordance to our 
findings, Margaritis et al did not observe any significant change in PSH concentrations in five 
healthy young males undergoing a six-month training program consisting of 29 training 
sessions, performed every three days, involving two types of exercise, the squat and the calf 
press. No specific parameters of muscle mass and function were assessed (Margaritis et al., 
2009). Pending further confirmation in longitudinal studies, our results do not suggest a 
significant role of PSH in terms of sarcopenia risk stratification and identification of 
responders to exercise training programs, based on changes in muscle strength, volume, and 
quality.  
The observation of sex-related differences in the markers studied, particularly TAU and HCY, 
suggests that the relationship between antioxidant and lipid peroxidation pathways and 
skeletal muscle homeostasis may be sex-specific. This, in turn, might help in the 
identification of tailored exercise programs in older males and females. However, the capacity 
of MDA to predict exercise-induced changes in MVC in both sexes suggests that this OS 
marker can predict treatment responders and that therapies targeting MDA and specific OS 
pathways might provide salutary effects on skeletal muscle homeostasis in old age.  
Our study has some limitations, including its relatively small sample size and the recruitment 
of participants without significant medical history. Therefore, it is unknown whether our 
results can be generalized to other older populations, particularly frail patients with 
sarcopenia. Nevertheless, it also has significant strengths, including the rigorous assessment 
of established pro- and anti-OS markers and established parameters of muscle mass and 
function. Furthermore, we ruled out the potential confounding effect of co-morbidities and 
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medications that can affect skeletal muscle structure and function, and closely supervised the 
exercise training program in all participants.  
In conclusion, the pro-oxidant markers MDA and HCY and the anti-oxidant marker TAU 
showed significant associations with baseline and/or exercise-induced changes in skeletal 
muscle mass and function in healthy older adults, particularly in females. Pending further 
confirmation in other study populations, these markers might be useful for sarcopenia risk 
stratification and prediction of responses to resistance exercise programs.  
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Table 1. Baseline characteristics 
  
Parameter Whole group 
(n=50) 
Males 
(n=27) 
Females 
(n=23) 
P-value* 
Age (years) 70 [67, 73] 69 [67, 72] 71 [68, 73] 0.544 
Height (cm) 169 [159, 176] 175 [172, 179] 159 [155, 168] <0.0001 
Weight (Kg) 72.1±15.1 78.1±15.0 65.1±12.3 0.002 
BMI (Kg/m2) 25.4±4.4 25.6±4.2 25.3±4.7 0.821 
eGFR (mL/min) 80±12 77±12 83±13 0.079 
Creatine (µmol/L) 168±76 134±51 208±83 0.001 
Creatinine (µmol/L) 79±12 85±10 71±9 <0.0001 
MVC (N•m) 90 [75, 120] 115 [94, 138] 76 [68, 85] <0.0001 
MIT (N•m) 116±37 141±32 86±14 <0.0001 
MCSA (cm2) 51 [38, 64] 63 [58, 68] 37 [32, 43] <0.0001 
MQ (N•m/cm2) 2.0±0.5 1.9±0.5 2.1±0.5 0.293 
HCY (µmol/L) 13.6±3.7 14.8±4.2 12.4±2.6 0.031 
TAU (µmol/L) 57.7±20.3 61.8±25.2 53.1±11.8 0.156 
MDA (µmol/L) 2.78±0.59 2.93±0.53 2.61±0.63 0.067 
PSH (µmol/L) 5.47±0.82 5.88±0.77 5.03±0.64 0.0001 
 
Data shown as mean ± SD or median [IQR] as appropriate 
BMI, body mass index; eGFR, estimated flomerular filtration rate; MVC, maximal voluntary 
contraction; MIT, maximal isokinetic torque; MCSA, muscle volume; MQ, muscle quality; 
HCY, homocysteine; TAU, taurine; MDA, malondialdehyde; PSH, sulphydril group of 
protein. 
Significant differences between males and females (P<0.05) are highlighted in bold. 
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Table 2. Baseline vs. post-exercise mean (95% CI) differences in oxidative stress 
markers in females and males 
 
 Mean (95% CI) difference P-value 
Females   
HCY +0.15 (-0.57 to 0.86) 0.673# 
TAU +4.24 (-1.67 to 10.16) 0.149 
MDA -0.27 (-0.51 to -0.02)  0.034 
PSH -0.19 (-0.41 to 0.03) 0.094 
Males   
HCY +0.25 (-0.75 to 1.25) 0.613 
TAU -7.06 (-16.08 to 1.95) 0.119 
MDA -0.09 (-0.28 to 0.11) 0.356 
PSH +0.07 (-0.21 to 0.36) 0.600 
 
HCY, homocysteine; TAU, taurine; MDA, malondialdehyde; PSH, sulphydril group of 
protein. 
Significant differences (P<0.05) are highlighted in bold. 
#, time * nutritional intervention interaction (P<0.05) 
 
 
 
 
 
 
 
 
 
 
 
 17 
Table 3. Partial correlations* between baseline oxidative stress markers and parameters 
of muscle mass and function in females  
 
 MVC  
(N•m) 
MIT  
(N•m) 
MCSA  
(cm2) 
MQ 
(N•m.cm2) 
HCY r= +0.143 
P=0.597 
r= +0.004 
P=0.988 
r= -0.447 
P=0.082 
r= +0.476 
P=0.062 
TAU r= +0.140 
P=0.58 
r= +0.53 
P=0.035 
r= +0.093 
P=0.732 
r= +0.073 
P=0.789 
MDA r= -0.448 
P=0.081 
r= +0.003 
P=0.99 
r= +0.021 
P=0.939 
r= -0.348 
P=0.186 
PSH r= +0.101 
P=0.711 
r= +0.384 
P=0.142 
r= +0.1 
P=0.713 
r= +0.055 
P=0.841 
 
*, adjusted for age and estimated glomerular filtration rate 
MVC, maximal voluntary contraction; MIT, maximal isokinetic torque; MCSA, muscle 
volume; MQ, muscle quality; HCY, homocysteine; TAU, taurine; MDA, malondialdehyde; 
PSH, sulphydril group of protein. 
Significant correlations (P<0.05) are highlighted in bold. 
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Table 4. Partial correlations* between oxidative stress markers and percent exercise-
induced changes in parameters of muscle mass and function in females  
 
 ∆%MVC  
(N•m) 
∆%MIT  
(N•m) 
∆%MCSA  
(cm2) 
∆%MQ 
(N•m.cm-2) 
HCY r= -0.155 
P=0.582 
r= +0.066 
P=0.816 
r= +0.522 
P=0.046 
r= -0.585 
P=0.022 
TAU r= +0.278 
P=0.316 
r= -0.112 
P=0.692 
r= +0.573 
P=0.026 
r= -0.009 
P=0.974 
MDA r= +0.6 
P=0.018 
r= -0.105 
P=0.709 
r= +0.036 
P=0.898 
r= +0.093 
P=0.741 
PSH r= +0.198 
P=0.480 
r= -0.258 
P=0.353 
r= +0.355 
P=0.194 
r= -0.404 
P=0.135 
 
*, adjusted for age, estimated glomerular filtration rate, and nutritional intervention 
MVC, maximal voluntary contraction; MIT, maximal isokinetic torque; MCSA, muscle 
volume; MQ, muscle quality; HCY, homocysteine; TAU, taurine; MDA, malondialdehyde; 
PSH, sulphydril group of protein. 
Significant correlations (P<0.05) are highlighted in bold. 
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Table 5. Partial correlations* between baseline oxidative stress markers and parameters 
of muscle mass and function in males  
 
 MVC  
(N•m) 
MIT  
(N•m) 
MCSA  
(cm2) 
MQ 
(N•m.cm-2) 
HCY r= +0.208 
P=0.38 
r= +0.151 
P=0.526 
r= +0.303 
P=0.194 
r= +0.72 
P=0.762 
TAU r= -0.111 
P=0.641 
r= +0.316 
P=0.175 
r= -0.407 
P=0.075 
r= +0.321 
P=0.167 
MDA r= +0.221 
P=0.349 
r= +0.293 
P=0.211 
r= +0.699 
P=0.001 
r= -0,122 
P=0.608 
PSH r= -0.179 
P=0.451 
r= -0.130 
P=0.585 
r= +0.341 
P=0.141 
r= -0.367 
P=0.111 
 
*, adjusted for age and estimated glomerular filtration rate 
MVC, maximal voluntary contraction; MIT, maximal isokinetic torque; MCSA, muscle 
volume; MQ, muscle quality; HCY, homocysteine; TAU, taurine; MDA, malondialdehyde; 
PSH, sulphydril group of protein. 
Significant correlations (P<0.05) are highlighted in bold. 
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Table 6. Partial correlations* between oxidative stress markers and percent exercise-
induced changes in parameters of muscle mass and function in males  
 
 ∆%MVC  
(N•m) 
∆%MIT  
(N•m) 
∆%MCSA  
(cm2) 
∆%MQ 
(N•m.cm-2) 
HCY r= +0.387 
P=0.101 
r= +0.303 
P=0.208 
r= +0.113 
P=0.645 
r= +0.341 
P=0.153 
TAU r= -0.043 
P=0.86 
r= -0.026 
P=0.916 
r= +0.388 
P=0.101 
r= -0.13 
P=0.595 
MDA r= +0.475 
P=0.04 
r= +0.226 
P=0.353 
r= +0.019 
P=0.937 
r= +0.44 
P=0.06 
PSH r= -0.93 
P=0.705 
r= -0.187 
P=0.444 
r= -0.184 
P=0.451 
r= -0.46 
P=0.852 
 
*, adjusted for age, estimated glomerular filtration rate, and nutritional intervention 
MVC, maximal voluntary contraction; MIT, maximal isokinetic torque; MCSA, muscle 
volume; MQ, muscle quality; HCY, homocysteine; TAU, taurine; MDA, malondialdehyde; 
PSH, sulphydril group of protein. 
Significant correlations (P<0.05) are highlighted in bold. 
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